AbbVie’s Skyrizi has been approved by the FDA as a treatment for ulcerative colitis, making it the first IL-23 inhibitor indicated for both major types of inflammatory bowel disease (IBD) – UC and ...
Boy, 11, Critically Hurt In Crash With Semi Near Paynesville An 11-year-old boy was critically hurt and four others were injured after a vehicle hit a semi-truck head-on near Paynesville Wednesday ...